Lantheus Holdings (LNTH)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Lantheus Holdings (LNTH)
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Key Insights
Critical company metrics and information
Share Price
$92.58Market Cap
$6.44 BillionTotal Outstanding Shares
69.53 Million SharesTotal Employees
834Dividend
No dividendIPO Date
June 25, 2015SIC Description
In Vitro & In Vivo Diagnostic SubstancesHomepage
https://www.lantheus.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $252.50 Million |
Net Cash Flow | $252.30 Million |
Net Cash Flow From Investing Activities, Continuing | $-231.48 Million |
Net Cash Flow From Financing Activities, Continuing | $-15.33 Million |
Net Cash Flow From Financing Activities | $-15.33 Million |
Exchange Gains/Losses | $-198,000.00 |
Net Cash Flow From Investing Activities | $-231.48 Million |
Net Cash Flow From Operating Activities | $499.31 Million |
Net Cash Flow From Operating Activities, Continuing | $499.31 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Other Operating Expenses | $339.43 Million |
Basic Average Shares | $69.27 Million |
Income Tax Expense/Benefit | $142.55 Million |
Revenues | $1.50 Billion |
Cost Of Revenue | $527.18 Million |
Gross Profit | $969.62 Million |
Operating Income/Loss | $480.59 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Net Income/Loss Attributable To Parent | $427.61 Million |
Basic Earnings Per Share | $6.21 |
Diluted Average Shares | $71.30 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Income/Loss From Continuing Operations After Tax | $427.61 Million |
Benefits Costs and Expenses | $926.64 Million |
Diluted Earnings Per Share | $6.02 |
Net Income/Loss | $427.61 Million |
Costs And Expenses | $926.64 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Net Income/Loss Available To Common Stockholders, Basic | $427.61 Million |
Operating Expenses | $489.02 Million |
Research and Development | $149.60 Million |
Income/Loss From Continuing Operations Before Tax | $570.16 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Equity Attributable To Parent | $1.18 Billion |
Current Liabilities | $784.08 Million |
Liabilities | $869.92 Million |
Wages | $35.74 Million |
Equity | $1.18 Billion |
Fixed Assets | $169.51 Million |
Intangible Assets | $173.61 Million |
Inventory | $70.83 Million |
Current Assets | $1.30 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Other Current Liabilities | $703.42 Million |
Noncurrent Liabilities | $85.84 Million |
Other Current Assets | $1.22 Billion |
Assets | $2.05 Billion |
Noncurrent Assets | $753.92 Million |
Liabilities And Equity | $2.05 Billion |
Accounts Payable | $44.91 Million |
Other Non-current Assets | $410.80 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.